Mandate

Vinge has advised Coop in connection with the acquisition of Netto’s Swedish grocery stores

May 16, 2019 M&A

Vinge has advised Coop Butiker & Stormarknader AB in connection with the acquisition of Netto’s Swedish grocery stores.

The transaction includes 163 grocery stores which will eventually be integrated and re-branded to Coop. Coop Butiker & Stormarknader AB operates 240 of Coop’s 650 grocery stores. The grocery stores are mainly located in Stockholm, Mälardalen, Östergötland and in the west of Skåne. The seller is Salling Group, Denmark’s largest consumer company, which, inter alia, operates Netto in Denmark, Germany, Poland and Sweden.
 
The acquisition is conditional upon customary closing conditions such as the approval of the Swedish Competition Authority.
 
Vinge’s team primarily consisted of responsible partners Daniel Rosvall and Niclas Winnberg together with, among others, associates Christoffer Nordin, Milad Kamali, Karolina Cohrs, Hampus Olsson, Valter Gran and VDR assistant Jessica Öijer. 
 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026